Respond publicly to an off-label request only when it names the firm's own product
AI-verifiedwarningFDA guidance · non-bindingRaised as a question — a person decides
Rule
A firm should respond to a public unsolicited off-label request only when the request pertains specifically to the firm's own named product, not solely to a competitor's product.
Check
Check that the public request being answered names or specifically concerns the firm's own product rather than only a competitor's product or a generic/unnamed drug class question.
Escalate when
Whether the original question was specific enough to the firm's named product is unclear.
Where this comes from
Section VI, Recommendation 1 · page 14. The highlighted words are quoted exactly; a script confirms they appear in the source before the rule can be published.
…detailed public online responses to off-label questions because specific drug or device information may become outdated (e.g., new risk information may become available). FDA makes the following recommendations to a firm that chooses to respond to public unsolicited requests for off-label information about its product(s), including those encountered through emerging electronic media. 1. If a firm chooses to respond to public unsolicited requests for off-label information, the firm should respond only when the request pertains specifically to its own named product (and is not solely about a competitor’s product). The level of specificity of the question posed in a public forum is important in determining the appropriateness of a firm responding to the unsolicited request. Example 13: An individual poses the specific question “Can Drug/Device X be used for Condition Y” in a public forum (and this question is not prompted by or on behalf of the firm). It may be appropriate for the firm to respond as outlined below becau…
- Document
- FDA guidance: Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices (see document)
- Version
- as retrieved — the publisher does not version this document; the fingerprint below identifies the exact file
- Retrieved
- 2026-09-21 from www.fda.gov
- Fingerprint
- 8ab6bfda34ad39a70987805b…
FDA guidance describes the agency's current thinking. It is not binding law, and this rule is a recommendation, not an obligation.